Ra Medical Systems Stock Gross Profit
RMEDDelisted Stock | USD 0.68 0.02 2.86% |
RA Medical Systems fundamentals help investors to digest information that contributes to RA Medical's financial success or failures. It also enables traders to predict the movement of RMED Stock. The fundamental analysis module provides a way to measure RA Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RA Medical stock.
RMED |
RA Medical Systems Company Gross Profit Analysis
RA Medical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current RA Medical Gross Profit | (1.54 M) |
Most of RA Medical's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RA Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, RA Medical Systems reported (1.54 Million) of gross profit. This is 100.07% lower than that of the Health Care Equipment & Supplies sector and 100.1% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.01% higher than that of the company.
RMED Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RA Medical's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RA Medical could also be used in its relative valuation, which is a method of valuing RA Medical by comparing valuation metrics of similar companies.RA Medical is currently under evaluation in gross profit category among its peers.
RMED Fundamentals
Return On Equity | -3.25 | |||
Return On Asset | -0.48 | |||
Operating Margin | (307.60) % | |||
Current Valuation | (8.89 M) | |||
Shares Outstanding | 6.46 M | |||
Shares Owned By Insiders | 36.84 % | |||
Shares Owned By Institutions | 11.00 % | |||
Number Of Shares Shorted | 81.45 K | |||
Price To Book | 0.86 X | |||
Price To Sales | 604.06 X | |||
Revenue | 14 K | |||
Gross Profit | (1.54 M) | |||
EBITDA | (18.2 M) | |||
Net Income | (26.86 M) | |||
Cash And Equivalents | 13.66 M | |||
Cash Per Share | 9.60 X | |||
Total Debt | 124.17 K | |||
Debt To Equity | 0.16 % | |||
Current Ratio | 4.83 X | |||
Book Value Per Share | 6.81 X | |||
Cash Flow From Operations | (22.57 M) | |||
Short Ratio | 0.13 X | |||
Earnings Per Share | (35.78) X | |||
Target Price | 7.0 | |||
Number Of Employees | 14 | |||
Beta | 0.18 | |||
Market Capitalization | 3.84 M | |||
Total Asset | 16.84 M | |||
Retained Earnings | (205.14 M) | |||
Working Capital | 9.26 M | |||
Z Score | -1.42 | |||
Net Asset | 16.84 M |
About RA Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RA Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RA Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RA Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |